Hongtai Aplus

The firm runs both strategies as parallel pillars. The direct team leads venture and growth-stage deals in Chinese technology companies, while the fund-of-funds team commits to external managers. This structure allows Aplus to capture direct returns while using manager relationships to source co-investment opportunities and benchmark market terms.

Aplus is stage-agnostic within private markets, deploying across seed, early-stage, expansion, late-stage, and pre-IPO rounds. The firm also participates in buyout and restructuring situations. This breadth is supported by separate teams for early-stage venture and later-stage growth equity within the direct investment arm.

The firm's primary investment focus is mainland China. While some portfolio companies pursue international expansion, Aplus's sourcing network and LP relationships remain concentrated domestically. The fund-of-funds portfolio may include managers with broader Asian mandates, but the direct portfolio is overwhelmingly China-focused.

Yes. Aplus sits within the Hongtai ecosystem, which includes Hongtai Capital Holdings, a diversified financial services and investment group. This affiliation provides Aplus with access to a broader LP network, shared infrastructure, and deal flow that originates across the parent group's activities in wealth management, securities, and insurance.

The firm targets technology-enabled sectors including autonomous driving, enterprise software, AI, healthcare services, financial technology, and mobility. Its portfolio construction reflects China's national technology priorities, with heavy weighting toward industrial tech and enterprise digitization alongside consumer-facing platforms.